Crossmark

Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas

Crossref DOI link: https://doi.org/10.1007/s10014-016-0260-x

Published Online: 2016-03-11

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takano, Shingo

Ishikawa, Eiichi

Sakamoto, Noriaki

Matsuda, Masahide

Akutsu, Hiroyoshi

Noguchi, Masayuki

Kato, Yukinari

Yamamoto, Tetsuya

Matsumura, Akira
Funding

Funding for this research was provided by:

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (15H04947)

Japan Brain Foundation

japanese Foundation for Multidiciplinary Treatment of Cancer
License Information

Text and Data Mining valid from 2016-03-11

Document is current

Any future updates will be listed below